Présentation de l'entreprise
Weave Communications, Inc. operates a specialized AI-powered platform designed to streamline patient communications, engagement, and payment processing specifically for small and medium-sized healthcare businesses. The company integrates advanced technologies such as an AI-receptionist, a unified phone number, and a customized phone system to intelligently identify the nature of incoming calls and enhance operational efficiency. Operating within the broader Healthcare sector and the specific Health Information Services industry, the firm leverages digital infrastructure to modernize clinical workflows and administrative tasks. The entity currently commands a market capitalization of $385.38M and generates annual revenue of $239.02M while employing a workforce of 904 individuals. These valuation and revenue figures indicate that the company occupies a significant, albeit niche, position within the health information services landscape, reflecting investor confidence in its technological differentiation despite current profitability challenges.
Santé financière
The company reported a trailing twelve-month revenue of $239.02M, yet this top-line activity resulted in a net income loss of $28,052,000 and an EBITDA of $-18,893,000, highlighting a substantial gap between gross revenue generation and bottom-line profitability driven by high operating costs or investment expenditures. Despite the negative net income and EBITDA, the company maintains robust financial flexibility with free cash flow reaching $45.32M, suggesting that core operations generate sufficient liquidity to cover capital expenditures and potentially fund strategic initiatives without relying solely on external financing. The margin profile reveals a gross margin of 72.1%, which indicates strong pricing power or low cost of goods sold, contrasted sharply by an operating margin of -3.2% and a profit margin of -11.7%, signaling that operating expenses are consuming a disproportionate amount of revenue. On the balance sheet, the firm holds $81.72M in cash against $52.15M in debt, resulting in a debt-to-equity ratio of 63.30, which implies a leveraged capital structure where equity is relatively limited compared to the debt burden. Liquidity is assessed via a current ratio of 1.24, indicating that the company possesses sufficient current assets to cover its short-term liabilities, though the buffer is not excessively wide. Return metrics further illustrate the financial strain, with a return on equity of -37.6% and a return on assets of -9.1%, revealing that management has yet to generate positive returns on the capital invested in the business during the current period.
Évaluation de la valorisation
Valuation multiples present a complex picture due to the lack of profitability, with the trailing P/E ratio listed as N/A because of negative earnings, while the forward P/E stands at 23.61, implying that the market prices in anticipated future earnings recovery. The price-to-book ratio is 4.66, which indicates that the stock trades at a significant premium relative to its book value, a common phenomenon for growth-oriented technology companies in the healthcare sector that possess valuable intangible assets. Alternative valuation metrics such as the price-to-sales ratio of 1.61 and an EV/EBITDA of -18.83 provide context, suggesting that investors are valuing the company primarily on its revenue growth potential rather than current earnings power. Regarding price action, the 52-week high is $11.32 and the 52-week low is $4.24, placing the current trading price within a range that reflects recent volatility and potential mean reversion dynamics. The stock exhibits a beta of 1.71, meaning it is significantly more volatile than the broader market, likely due to its concentration in a specific sub-sector and sensitivity to healthcare technology adoption rates or regulatory changes.
Growth & Income
Revenue growth for the trailing twelve-month period stands at 17.0%, demonstrating strong top-line expansion, whereas earnings growth is N/A due to the absence of positive net income in the current period. This divergence implies that while the business is successfully capturing market share and increasing sales volume, it has not yet translated this growth into bottom-line profitability, likely due to the heavy investment in AI infrastructure and platform development. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which indicates a strategy of retaining all earnings to fund growth initiatives and reduce the high debt load rather than distributing income to shareholders. Consequently, the overall growth and income profile is characterized by aggressive reinvestment in revenue expansion at the expense of current shareholder yield, a typical profile for capital-intensive technology firms in their growth phase.